Search
for
Sort by
Research 121–150 of 1000+
- Thymosin β4 Promotes Dermal Healing
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway
- Male Pattern Baldness
- Editor's Picks August 2023
- The Role of Platelet-Rich Plasma in the Management of Ankle Osteoarthritis: A Systematic Review
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Alopecia in patients treated with molecularly targeted anticancer therapies
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications
- Clinical and microscopic evaluation of long-term (6 months) epilation effects of the ipulse personal home-use intense pulsed light (IPL) device
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Clinical Development of Topoisomerase-Interactive Drugs
- The Effectiveness of Cerium Oxide Nanoparticle-Based Drugs in Wound Healing in Animal Models
- Alopecia - the search for novel agents continues
- News in brief
- The PDGF/PDGFR pathway as a drug target
- Combination Therapies and the Theoretical Limits of Evidence-Based Medicine
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- The Use of Neurotoxins in the Male Face
- Slow progress in prostate cancer
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Racial and Ethnic Disparities in Androgenetic Alopecia Clinical Trials in the United States
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives